Duration of treatment, behavioural changes made during that time, dietary patterns established, and baseline metabolic health all influence what happens after stopping GLP-1 medication
You get the energy benefits without unwanted side effects
In vivo , apigenin reduces the secretion of pro-inflammatory factors (IL-1, IL-6, and TNF-), reduces the expression of the DCs costimulatory molecules CXCR4 and MHCII, and reduces the number of Langerhans cells
Research by Acosta has shown that people with the hungry-gut type lose more weight on GLP-1 drugs than the other types
The decision to use a peptide should account for diagnosis, comorbidities, other medications, pregnancy status where relevant, cancer history where relevant, cardiometabolic risk, organ function, and intended treatment goals
If youre not eligible through the NHS, Mounjaro is available to buy online through our weight loss clinic, subject to eligibility